close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Globus Medical, Inc. Class A Common Stock (NY:GMED)

71.05 -10.39 (-12.76%)
Official Closing Price Updated: 7:00 PM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Globus Medical Q3 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Why Globus Medical (GMED) shares are plunging today
What happened? Shares of medical device company Globus Medical (NYSE:GMED) fell 11.6% in the afternoon session after the company reported third-quarter 2026 ... 
Via StockStory
News headline image
Globus Medical (GMED) Q3 2026 Earnings Call Transcript ↗
Record free cash flow offset a revenue dip and a lower full-year outlook. 
Via The Motley Fool
Topics Earnings
News headline image
GMED Q3 2026 deep dive: product launch delays and Nevro drag outlook, margin improvement offsets
Medical device company Globus Medical (NYSE:GMED) missed Wall Street’s revenue expectations in Q3 2026, with sales flat year on year at $763.7 million. The c... 
Via StockStory
Globus Medical (NYSE:GMED): A Balanced Affordable Growth Case ↗
Via Chartmill
Globus Medical (NYSE:GMED): A Quality Investing Case Built on Durable Growth ↗
Via Chartmill
Globus Medical (NYSE:GMED): A Decent Value Stock With Solid Fundamentals ↗
Via Chartmill
Globus Medical (NYSE:GMED): A Compelling Affordable Growth Opportunity ↗
Via Chartmill
News headline image
Globus Medical (NYSE:GMED) reports sales below analyst estimates in Q3 2026 earnings
Medical device company Globus Medical (NYSE:GMED) fell short of the market’s revenue expectations in Q3 2026, with revenue flat year on year at $763.7 millio... 
Via StockStory
News headline image
Globus Medical Reports Third Quarter 2026 Results and Announces a $500 Million Increase to the Share Repurchase Program
From Globus Medical
Via GlobeNewswire
News headline image
iRhythm, ICU Medical, Globus Medical, Enovis, and CONMED shares are soaring, what you need to know
What happened? A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in the House and Senat... 
Via StockStory
News headline image
Globus Medical (GMED) reports earnings tomorrow: what to expect
Medical device company Globus Medical (NYSE:GMED) will be reporting results this Thursday after market close. Here’s what to expect. Globus Medical beat anal... 
Via StockStory
Topics Artificial Intelligence
Globus Medical (NYSE:GMED) Shares Rise on Q2 Earnings Beat and Raised Profit Guidance ↗
Via Chartmill
Topics Earnings
Globus Medical (GMED) Emerges as a Decent Value Stock with Strong Fundamentals ↗
Via Chartmill
News headline image
Globus Medical Acquires Synaptive Medical, Strengthening Its Position in Cranial Neurosurgery
From Globus Medical
Via GlobeNewswire
News headline image
2 cash-producing stocks with promising prospects and 1 we avoid
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026
New Innovations Designed to Advance Patient-Specific Planning and Connected Surgical Workflows 
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
News headline image
1 Mid-Cap Stock for Long-Term Investors and 2 We Ignore
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe... 
Via StockStory
News headline image
2 Reasons to Watch GMED and 1 to Stay Cautious
Over the last six months, Globus Medical’s shares have sunk to $74.94, producing a disappointing 10.3% loss - a stark contrast to the S&P 500’s 21.4% gain. T... 
Via StockStory
Topics Stocks
News headline image
Q2 Earnings Highs And Lows: Globus Medical (NYSE:GMED) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including Gl... 
Via StockStory
News headline image
3 Profitable Stocks on Our Watchlist
Profitable companies tend to be more resilient, giving them the flexibility to invest and return capital to shareholders. Businesses that consistently genera... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stocks on Our Watchlist and 2 Facing Challenges
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
Globus Medical Announces CE Mark for Excelsius3D™ Imaging System
Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem in the European Union 
From Globus Medical
Via GlobeNewswire
News headline image
1 Growth Stock to Stash and 2 We Turn Down
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil... 
Via StockStory
News headline image
Globus Medical Announces Acquisition of Higgs Boson Health to Transform Healthcare Experience Through AI-Driven Digital Solutions
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical Q2 Earnings Call Highlights ↗
Globus Medical (NYSE:GMED) reported second-quarter 2026 revenue of $789.6 million, up 6% from a year earlier, as growth in its spine and trauma businesses helped offset declines in enabling... 
Via MarketBeat
Topics Earnings
News headline image
Globus Medical (NYSE:GMED) Beats Q2 CY2026 Sales Expectations
Medical device company Globus Medical (NYSE:GMED) announced better-than-expected revenue in Q2 CY2026, with sales up 5.9% year on year to $789.6 million. The... 
Via StockStory
News headline image
Globus Medical Reports Second Quarter 2026 Results
From Globus Medical
Via GlobeNewswire
News headline image
What To Expect From Globus Medical’s (GMED) Q2 Earnings
Medical device company Globus Medical (NYSE:GMED) will be announcing earnings results this Thursday afternoon. Here’s what you need to know. Globus Medical b... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.